Please use this identifier to cite or link to this item: https://ir.swu.ac.th/jspui/handle/123456789/17180
Full metadata record
DC FieldValueLanguage
dc.contributor.authorWongwattana P.
dc.contributor.authorWiriyaamornchai P.
dc.date.accessioned2022-03-10T13:16:36Z-
dc.date.available2022-03-10T13:16:36Z-
dc.date.issued2021
dc.identifier.issn1252208
dc.identifier.other2-s2.0-85116009372
dc.identifier.urihttps://ir.swu.ac.th/jspui/handle/123456789/17180-
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85116009372&doi=10.35755%2fjmedassocthai.2021.S03.00004&partnerID=40&md5=e1646f8f7f3b3a068ca907cb44d57983
dc.description.abstractParathyroid carcinoma is a very rare cancer, accounting for 0.5% to 5% of all causes of primary hyperparathyroidism. Parathyroid carcinoma has an equal frequency of occurrence in both genders, usually in the fifth decade of life. Preoperative diagnosis of parathyroid carcinoma is difficult due to a lack of clinical findings, laboratory results, or radiological characteristics specific to the disease. Though, parathyroid carcinoma patients usually present with severe hypercalcemia at the time of diagnosis. Complete en-bloc resection is the mainstay of the treatment. The adjuvant therapy such as radiotherapy or chemotherapy has not shown effective in the treatment of parathyroid carcinoma. © JOURNAL OF THE MEDICAL ASSOCIATION OF THAILAND, 2021.
dc.languageen
dc.subjectalkaline phosphatase
dc.subjectbisphosphonic acid derivative
dc.subjectcalcitonin
dc.subjectdacarbazine
dc.subjectdenosumab
dc.subjectdoxorubicin
dc.subjectfluorouracil
dc.subjectlomustine
dc.subjectmethotrexate
dc.subjectmethoxy isobutyl isonitrile technetium tc 99m
dc.subjectsorafenib
dc.subjectadjuvant therapy
dc.subjectAkt/mTOR signaling
dc.subjectanorexia
dc.subjectcancer staging
dc.subjectcell proliferation
dc.subjectcomputer assisted tomography
dc.subjectdata base
dc.subjectdisease classification
dc.subjectdistant metastasis
dc.subjectechography
dc.subjecten bloc resection
dc.subjectend stage renal disease
dc.subjectenvironmental factor
dc.subjectfine needle aspiration biopsy
dc.subjectgene mutation
dc.subjecthistology
dc.subjecthistopathology
dc.subjecthuman
dc.subjecthypercalcemia
dc.subjecthyperparathyroidism
dc.subjecthypoparathyroidism
dc.subjectimmunohistochemistry
dc.subjectjaw tumor
dc.subjectlung metastasis
dc.subjectlymph node metastasis
dc.subjectmonotherapy
dc.subjectmorbidity
dc.subjectnuclear magnetic resonance imaging
dc.subjectparathyroid adenoma
dc.subjectparathyroid carcinoma
dc.subjectparathyroid hyperplasia
dc.subjectpathogenesis
dc.subjectpathology
dc.subjectpolydipsia
dc.subjectpolyuria
dc.subjectpositron emission tomography
dc.subjectpositron emission tomography-computed tomography
dc.subjectReview
dc.subjectscintigraphy
dc.subjecttreatment response
dc.subjecttumor invasion
dc.subjecttumor suppressor gene
dc.subjecttumor volume
dc.subjectvomiting
dc.subjectweakness
dc.titleParathyroid carcinoma
dc.typeReview
dc.rights.holderScopus
dc.identifier.bibliograpycitationJournal of the Medical Association of Thailand. Vol 104, No.9 (2021), p.S83-S90
dc.identifier.doi10.35755/jmedassocthai.2021.S03.00004
Appears in Collections:Scopus 1983-2021

Files in This Item:
There are no files associated with this item.


Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.